Agios Pharmaceuticals (AGIO) Treasury Shares (2021 - 2026)

Agios Pharmaceuticals (AGIO) has 6 years of Treasury Shares data on file, last reported at $802.5 million in Q2 2026.

• Quarterly Treasury Shares changed 0.0% year-over-year to $802.5 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $802.5 million (changed 0.0% YoY) and the FY2025 annual result came in at $802.5 million, changed 0.0% from the prior year.
• Treasury Shares held at $802.5 million in Q2 2026, from $802.5 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $16.2 billion in Q1 2022 to a low of $16.2 million in Q4 2022.
• A 5-year average of $10.8 billion and a median of $16.2 billion in 2022 frame the typical range for Treasury Shares.
• The widest YoY moves for Treasury Shares: up 51.69% in 2022, down 0.0% in 2022.
• Tracing AGIO's Treasury Shares over 5 years: stood at $802.5 million in 2022, then changed by 0.0% to $802.5 million in 2023, then changed by 0.0% to $802.5 million in 2024, then changed by 0.0% to $802.5 million in 2025, then changed by 0.0% to $802.5 million in 2026.
• The last three Treasury Shares figures came in at $802.5 million (Q2 2026), $802.5 million (Q1 2026), and $802.5 million (Q4 2025), per Business Quant data.